Robert Duggan, biotech entrepreneur and investor, built his fortune by identifying overlooked medical assets and scaling them into blockbuster businesses. He is best known for leading Pharmacyclics as CEO and majority owner, turning the company into a major oncology success through the development of Imbruvica, before selling it to AbbVie in a multibillion-dollar deal. Known for bold conviction, aggressive capital deployment, and a willingness to bet heavily on scientific outcomes, Duggan has become one of the most successful dealmakers in modern biotechnology.

Robert Agostinelli, cofounder and chairman of Rhone Group, is a veteran global private equity investor known for cross-border dealmaking and long-term ownership in industrial and services businesses. After an early career in banking and finance, he helped build Rhone into a prominent international investment firm with a focus on complex, global situations and value creation through operational improvement. Agostinelli is also well known for philanthropy and policy engagement, supporting education, democracy initiatives, and transatlantic civic programs while maintaining influence across business and public affairs.

Richard Perry, founder of Perry Capital, was one of Wall Street’s most recognized hedge fund managers, known for event-driven investing and complex special situations across credit and equities. After early success at Goldman Sachs, Perry launched Perry Capital in 1988 and built it into a multibillion-dollar firm with a reputation for aggressive risk-taking and sophisticated arbitrage strategies. At its peak, the fund was a major player in merger arbitrage, distressed debt, and structured credit, navigating both market booms and severe downturns. Though the firm ultimately closed after years of volatility and underperformance, Perry remains a defining figure of the hedge fund era.

Richard LeFrak, chairman and CEO of LeFrak Organization, leads one of America’s most enduring real estate dynasties, overseeing a vast portfolio of residential, commercial, and mixed-use assets. Building on the legacy of his father Samuel LeFrak, he expanded the family’s holdings across New York, New Jersey, and Florida, including landmark developments such as Newport in Jersey City. Known for long-term ownership, disciplined capital deployment, and large-scale urban development, LeFrak has shaped major waterfront and city-center projects while maintaining the firm as a privately held powerhouse.

Richard Kurtz, founder and chairman of Kamson Corporation, built a major privately held real estate company specializing in multifamily and mixed-use properties across the Northeastern United States. Starting with a focus on apartment ownership and management, Kurtz grew Kamson through disciplined acquisitions, property repositioning, and long-term operational control, creating a large portfolio spanning residential communities and commercial assets. Known for quiet execution and a patient, cash-flow-driven strategy, he has maintained Kamson as a durable family-led platform through multiple real estate cycles.

Dick DeVos, businessman and former CEO of Amway, is a member of one of America’s most prominent entrepreneurial families, helping expand the global direct-selling giant founded by his father, Rich DeVos. During his leadership, DeVos focused on international growth and organizational modernization while maintaining Amway’s multi-generational ownership structure. Beyond business, he is a major civic and philanthropic figure in Michigan, supporting education, healthcare, and community development, and he has also been active in politics and public policy debates. His career reflects a blend of family enterprise stewardship, institutional leadership, and regional impact.

Reinhold Schmieding, founder and CEO of Arthrex, built one of the world’s most influential orthopedic device companies by focusing on minimally invasive surgical innovation. After launching Arthrex in 1981, Schmieding transformed it into a global leader in sports medicine, arthroscopy, and surgical implants, supplying cutting-edge tools and techniques to surgeons worldwide. Known for obsessive product development, surgeon education, and privately held discipline, he scaled Arthrex into a multibillion-dollar enterprise while maintaining a strong culture of engineering and clinical excellence.

Randal J. Kirk, biotech entrepreneur and investor, built his fortune by creating and scaling life-sciences companies focused on drug development, specialty pharmaceuticals, and healthcare innovation. Best known as the founder of Intrexon and as the driving force behind multiple public biotech ventures, Kirk has pursued an aggressive strategy of acquiring scientific platforms, recruiting top research talent, and commercializing high-value therapies. His long-term influence spans pharmaceuticals, genetics, and medical technology, reflecting a rare ability to combine capital markets skill with scientific ambition.

Rakesh Gangwal, cofounder of IndiGo, helped build India’s largest airline by applying rigorous cost discipline, operational simplicity, and scale economics to commercial aviation. Drawing on decades of global airline experience, including senior roles at United Airlines and US Airways, Gangwal co-launched IndiGo in 2006 with a sharp focus on on-time performance, single-aircraft fleets, and low-cost efficiency. The strategy transformed IndiGo into the dominant carrier in one of the world’s fastest-growing aviation markets, reshaping air travel across India.

Rajiv Jain, founder and chief investment officer of GQG Partners, built one of the fastest-growing global asset managers by applying a disciplined, long-term approach to emerging and developed market equities. After a long tenure at Vontobel, Jain launched GQG in 2016 with a focus on fundamental research, downside protection, and concentrated portfolios. The firm quickly scaled to manage tens of billions of dollars for institutions and wealth clients worldwide, earning a reputation for resilience across volatile market cycles. Jain is known for his independent thinking, conservative risk posture, and consistent performance.

Phillip Frost, physician and entrepreneur, built a biotechnology empire by identifying undervalued medical assets and scaling them through disciplined science-driven investing. As founder and chairman of OPKO Health, Frost assembled a diversified healthcare platform spanning diagnostics, pharmaceuticals, and medical technologies, often through strategic acquisitions and partnerships. Earlier in his career, he sold IVAX Corporation to Teva in a multibillion-dollar transaction, cementing his reputation as a leading dealmaker in life sciences. Known for a long-term approach to innovation and capital allocation, Frost remains a central figure in global healthcare entrepreneurship.

Paul Tudor Jones, founder and chief investment officer of Tudor Investment Corporation, is a legendary macro trader best known for predicting and profiting from the 1987 stock market crash. Over decades, Jones built one of the world’s most respected hedge funds by combining global macroeconomic analysis with disciplined risk management. Beyond finance, he is a pioneer of impact investing and philanthropy, founding Robin Hood to combat poverty and advocating for market reforms tied to sustainability and social outcomes. His career reflects a rare blend of trading mastery, adaptability across cycles, and civic engagement.

Paul Saville, longtime executive and vice chairman of NVR, is one of the key architects behind one of the most consistently profitable homebuilders in the United States. As a senior partner of investor David A. Tepper in NVR’s early years, Saville helped shape the company’s distinctive, asset-light business model, emphasizing land optioning, strict cost controls, and disciplined capital allocation. This approach allowed NVR to outperform peers across housing cycles while maintaining high returns on equity and a strong balance sheet. Saville’s influence reflects a rare blend of financial rigor and operational restraint in a cyclical industry.

Patrick Zalupski, founder and CEO of Dream Finders Homes, built one of the fastest-growing homebuilders in the United States by focusing on asset-light land strategies and disciplined capital allocation. After founding the company in 2008, Zalupski emphasized lot optioning, regional market expertise, and operational efficiency, allowing Dream Finders to scale rapidly while maintaining strong margins. The company went public in 2021, cementing its position as a major player in residential construction across high-growth Sun Belt markets. Zalupski’s approach blends entrepreneurial speed with conservative balance-sheet management in a cyclical industry.

Orlando Bravo, cofounder and managing partner of Thoma Bravo, built one of the most powerful private equity franchises in software by applying a disciplined, repeatable playbook to mission-critical technology businesses. After early success investing in cybersecurity and enterprise software, Bravo scaled Thoma Bravo into a dominant global platform known for operational improvement, buy-and-build strategies, and long-term value creation. His focus on recurring revenue models and founder-aligned execution has reshaped how private equity approaches software at scale.

Norman Braman, founder and chairman of Braman Automotive Group, built one of the largest luxury auto dealership empires in the United States by focusing on premium brands, prime real estate, and disciplined operations. Starting in the 1970s, Braman expanded aggressively in South Florida, assembling a portfolio that includes top marques such as BMW, Mercedes-Benz, Porsche, and Rolls-Royce. Beyond automotive retail, he is a prominent civic figure and philanthropist, investing heavily in healthcare, education, and urban development in Miami. Braman’s career blends entrepreneurial scale with sustained local impact.

Nick Caporella, founder and longtime chairman of National Beverage Corp., built one of the most distinctive players in the U.S. beverage industry by betting early on healthier, flavor-forward drinks. After acquiring the company in the 1980s, Caporella focused on brand-led growth rather than scale-for-scale’s sake, turning LaCroix into a cultural phenomenon and a leader in sparkling water. Known for frugality, tight control, and unconventional strategy, he created outsized value with a small portfolio and an intense focus on margins and brand equity.

Nelson Peltz, founder and CEO of Trian Fund Management, is one of the most prominent activist investors in corporate America, known for pushing operational discipline and shareholder-focused governance at some of the world’s largest companies. After early success building food distributor Triangle Industries, Peltz turned to activism through Trian, taking influential stakes in companies such as Procter & Gamble, PepsiCo, DuPont, and General Electric. His campaigns typically emphasize cost control, capital allocation, and strategic clarity rather than breakups, earning him a reputation as a boardroom power broker. Peltz’s blend of industrial experience and financial activism has reshaped how large corporations respond to shareholder pressure.

Micky Arison, chairman of Carnival Corporation, built the world’s largest cruise company into a dominant force in global leisure travel while also shaping professional sports as owner of the Miami Heat. After taking the helm of his family’s cruise business, Arison expanded Carnival through scale, brand diversification, and operational efficiency, overseeing multiple marquee cruise lines and a vast global fleet. Beyond travel, he transformed the Heat into an NBA powerhouse with multiple championships, applying a disciplined, culture-driven ownership style. Known for a low public profile and long-term focus, Arison remains one of the most influential figures in hospitality and sports ownership.

Michael S. Smith, cofounder, chairman, and CEO of Freeport Financial Partners, has built one of the leading private credit platforms focused on non-sponsored middle-market lending. Since launching Freeport in 2008, Smith has emphasized disciplined underwriting, downside protection, and long-term relationships with founder-led businesses, helping the firm scale into a multibillion-dollar manager. A veteran of leveraged finance, he guided Freeport through market cycles by prioritizing capital preservation and consistent income, earning the firm a reputation for reliability among institutional investors. Smith’s steady leadership has positioned Freeport as a cornerstone player in private direct lending.